HUMANIZED ANTIBODY THAT SHOWS CAPACITY TO BIND ErbB2 AND BLOCK ACTIVATION OF ErbB2 RECEPTOR BY LIGAND (VARIANTS) AND COMPOSITION FOR USING IN CANCER TREATMENT COMPRISING THIS ANTIBODY Russian patent published in 2006 - IPC A61K39/395 C07K16/18 A61K47/48 A61P35/00 

Abstract RU 2270029 C2

FIELD: medicine, oncology, immunology.

SUBSTANCE: invention relates to humanized antibodies with ErbB2. Invention involves the development of new humanized antibodies raised to tyrosinase receptors of family ErbB2, and to a composition comprising these antibodies. The advantage of invention involves expanding region in using indicated antibodies in cancer treatment wherein receptor of epidermal growth factor, EGFR, is a target of these antibodies.

EFFECT: valuable properties of antibody.

14 cl, 3 tbl, 13 dwg

Similar patents RU2270029C2

Title Year Author Number
MEANS OF IDENTIFICATION OF TUMOURS, ACQUISITIVE TO TREATMENT BY ANTIBODIES AGAINST ErbB2 2003
  • Koll' Khans
  • Bossenmajer Birgit
  • Mjuller Khans-Joakhim
  • Slivkovski Mark K.
  • Kelsi Stefen Majkl
RU2338751C2
THERAPY OF MALIGNANT TUMOR, RESISTANT TO PLATINUM-BASED MEDICATIONS 2005
  • Kelsi Stefen M.
RU2403065C2
COMPOSITION OF HER2 ANTIBODIES 2005
  • Kao Jun-Sian
  • Vanderlan Martin
RU2361880C2
COMPOSITION CONTAINING ANTIBODY BINDING TO DOMAIN II OF HER2, AND ITS ACIDIC VERSIONS 2009
  • Kharris, Rid, Dzh.
  • Motchnik, Pol, A.
RU2543664C2
PHARMACEUTICAL COMPOSITIONS AIMED AT Erb-B1 RECEPTORS 2003
  • Krejsh Khans-Georg
  • Shmidt Jurgen
RU2354402C2
INTRODUCTION OF FIXED DOSES OF HER-ANTIBODIES 2005
  • Ehllison Dehvid E.
  • Brjuno Rene
  • Lu Tszjan'-Fyn
  • Ng Chee M.
RU2438705C2
COMPOSITIONS OF ANTIBODIES 2005
  • Ehnd'Ja Dzhejms D.
  • Gvi Shian K.
  • Lju Tszjun'
  • Shehn' E
RU2426554C2
COMBINED THERAPY USING INHIBITORS OF TYROSINE KINASE RECEPTORS AND INHIBITORS OF ANGIOGENESIS 2001
  • Gudman Sajmon
  • Krejsh Khans-Georg
RU2292904C2
SELECTION OF MEDICATIONS FOR LUNG CANCER THERAPY BY MEANS OF ANTIBODY-BASED MATRICES 2008
  • Singkh Sharat
  • Kharvi Zhanna
RU2519647C2
SINGLE-DOMAIN MINI-ANTIBODY aHER2/aSKBR3-1, SPECIFICALLY BINDING EPIDERMAL GROWTH FACTOR RECEPTOR HER2/ERBB2/neu AND CAPABLE TO PENETRATE THROUGH THIS INTERACTION INTO TARGET CELLS (INTERNALISED), METHOD OF PRODUCTION OF THIS ANTIBODY AND METHOD OF DETECTION OF PROTEIN HER2/ERBB2/neu AND CELLS EXPRESSING THIS PROTEIN IN INCREASED AMOUNT, USING MINI-ANTIBODY aHER2/aSKBR3-1 2012
  • Tillib Sergej Vladimirovich
  • Ivanova Tat'Jana Il'Inichna
  • Vasil'Ev Lev Anatol'Evich
  • Deev Sergej Mikhajlovich
  • Zdobnova Tat'Jana Aleksandrovna
  • Zagajnova Elena Vadimovna
RU2522929C2

RU 2 270 029 C2

Authors

Adams Kamellia U.

Presta Lenard G.

Slivkovski Mark

Dates

2006-02-20Published

2000-06-23Filed